Edible Garden AG Incorporated (EDBL) operates in controlled environment agriculture, growing organic herbs and produce while expanding into shelf-stable and ready-to-drink nutrition via its Farm-to-Formula platform. Analyst coverage remains thin, with only one verifiable current target. In June 2026, Maxim Group’s Anthony Vendetti adjusted the price target to $1.00 (split-adjusted) from $80, retaining a Buy rating due to the nutrition transition but accounting for dilution and execution risks. A single target does not create a true consensus, so this $1 figure acts as a reference drawn from available public commentary. It also matches Nasdaq Listing Rule 5550(a)(2), which sets the minimum closing bid price at $1.00. Older, unadjusted figures from data providers that predate the 1-for-45 reverse split in July 2026 are not reliable and have been set aside.
Shares recently traded near $0.70, inside a 52-week range with a low around $0.66. Closing the gap to $1.00 would require an advance of roughly 43%. The company posted trailing revenue of about $13.8 million against a net loss near $24 million, held roughly $658,000 in cash, and carried a debt-to-equity ratio above 260%. Progress toward the target would likely hinge on signs that the nutrition strategy can lift margins and ease cash consumption while maintaining Nasdaq compliance.
Management has highlighted expansion at the Webster City facility for ready-to-drink production and a move into higher-margin, shelf-stable nutrition items. Regaining Nasdaq compliance in September 2026 eased immediate delisting worries, and products are now available in thousands of retail locations. The lone Buy rating, the $1 reference point, and the psychological weight of the $1.00 threshold may draw additional focus to that level. I also checked this using Tickeron’s AI Screener to compare the stock’s profile with peers in the sector.
Substantial challenges remain. The company continues to post losses, maintains limited cash, and operates with high leverage, leaving little margin for error. Repeated reverse stock splits point to ongoing dilution and balance-sheet pressure, while EPS stays deeply negative (though warrant accounting affects the reported figure). Nasdaq placed the firm under a Mandatory Panel Monitor for one year starting late August 2026, so any fresh breach of the bid-price rule could lead to faster delisting. Weak demand, packaged-food competition, and broader pressure on small-cap stocks could further dampen sentiment.
From a technical perspective, $1.00 stands as the key level, serving both as psychological resistance and the Nasdaq compliance threshold. The 52-week low near $0.66 offers the nearest notable support. Holding above $1.00 on a sustained basis would mark an important structural shift, whereas a drop below $0.66 could revive delisting concerns and reduce the case for the target. One thing that stands out here is how tightly the technical and regulatory lines coincide.
The single analyst target implies a roughly 12-month research horizon, though no firm deadline applies. Investors should track the next earnings release, expected around mid-November 2026, along with any updates on revenue growth, cash burn, further analyst changes, and Nasdaq monitoring developments through late November 2026. The Mandatory Panel Monitor period and any new financing moves will provide additional signals. I’m watching this closely as the earnings date approaches.
Tickeron’s AI Daily Buy/Sell Signals apply artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on market shifts, technical patterns, and AI analysis. For a thinly followed, volatile micro-cap such as EDBL, these signals can help surface opportunities, track positions, and identify trend changes more efficiently than manual review alone. I find this approach useful as part of a wider research routine when coverage is limited.
The $1 target for Edible Garden functions as a reference point based on one current analyst target and Nasdaq’s minimum bid price rule rather than a broad consensus. With the stock near $0.70, the implied upside of roughly 43% represents a substantial move. The main supports lie in the nutrition-product strategy and restored listing compliance, while persistent losses, constrained cash, dilution, and delisting risk remain the primary hurdles. Given the thin coverage, the figure should be viewed as a reference rather than a firm forecast, and close attention to earnings, cash flow, and Nasdaq oversight is warranted.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where EDBL declined for three days, in 369 of 380 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for EDBL entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +6.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where EDBL advanced for three days, in 118 of 138 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
EDBL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.346) is normal, around the industry mean (2.266). P/E Ratio (-0.001) is within average values for comparable stocks, (4.366). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.441). EDBL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (0.005) is also within normal values, averaging (2.353).
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. EDBL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDBL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AgriculturalCommoditiesMilling